3 Top-Ranked Stocks to Buy and Hold for 2026
Investing·2026-01-09 17:06

Group 1: Eli Lilly and Company - Eli Lilly reported a significant increase in revenue, driven by strong sales of its diabetes and cancer drugs, with a year-over-year growth of 15% [1] - The company has expanded its pipeline with new drug candidates, aiming to address unmet medical needs in various therapeutic areas [1] - Eli Lilly's strategic focus on innovation and market expansion is expected to enhance its competitive position in the pharmaceutical industry [1] Group 2: Weatherford International PLC - Weatherford International has shown improvement in operational efficiency, resulting in a 10% reduction in costs compared to the previous year [1] - The company is benefiting from the recovery in oil prices, which has led to increased demand for its services in the oil and gas sector [1] - Weatherford's strategic initiatives include enhancing its technology offerings to better serve its clients and capture market share [1] Group 3: Pagaya - Pagaya has experienced rapid growth in its asset management business, with assets under management increasing by 25% over the last quarter [1] - The company is leveraging advanced data analytics to optimize investment strategies and improve returns for its clients [1] - Pagaya's focus on technology-driven solutions positions it well in the competitive landscape of financial services [1]